Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

How do I Recognize and Treat the VEXAS Syndrome?

Cleveland Clinic Rheumatology

P. Grayson

How to Approach Anemia

Icahn School of Medicine at Mount Sinai

C. Cromwell

Impact and Risks of Chronic Anemia in Thalassemia Patients

Farrukh Shah

Anemia: Beyond Iron Deficiency!

Scripps Health

A. Goodman

CAR T-Cell vs. Bispecific Therapies for Blood Cancers: How Oncologis…

GRACE

A. Goodman, A. Jeong, S. Rajeeve

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Indy Hematology Review

R. Birhiray

Managing Benign Hematology Disorders

Indy Hematology Review

C. Kessler

Endocrine Adverse Events From Checkpoint Inhibitors

Yale Cancer Center

K. Herold

Cellular Therapy in 2024: What, Why, When, Who… and Where Are We Goi…

University of Colorado Department of Medicine

J. Gutman

CAR T-Cell Therapy in Autoimmune Disorders

Vanderbilt University Medical Center (VUMC)

O. Oluwole

Severe Anemia: Indications for Blood Transfusion, Initial Work Up, a…

APP2APP Virtual Lectures, Inc

D. Thomas

Debates in CLL: Measuring MRD is NOT the SOC

UChicago Medicine

J. Soumerai

Hematopathology Tumor Board: Case Studies and Diagnostic Challenges …

UChicago Medicine

G. Venkataraman, A. Perry, K. Cahill, A. Akmatbekov, L. Wu

CAR T-Cell Therapy Side Effects for Blood Cancers

GRACE

A. Goodman

CAR NK Cells: Next Generation Cell Therapies for Cancer

University of Colorado Cancer Center

K. Rezvani